EUVIMEDEUVIMED entdecken
Crossref

DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression

Shoukat Afshar-Sterle iD, Annalisa L E Carli iD, Ryan O'Keefe iD, Janson Tse, Stefanie Fischer iD, Alexander I Azimpour, David Baloyan iD, Lena Elias iD, Pathum Thilakasiri, Onisha Patel iD, Fleur M Ferguson iD, Moritz F Eissmann iD und 7 weitere

Science Signaling · 17.09.2024 · 17 (854)

DOI: 10.1126/scisignal.abq4888 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, erschienen am 17.09.2024. Verfasst von Shoukat Afshar-Sterle und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. Hauptthemen laut MEDLINE: Doublecortin-Like Kinases, Stomach Neoplasms, Protein Serine-Threonine Kinases, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellowship, Program Grant, Investigator Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doublecortin-like kinase 1 (DCLK1) is a proposed driver of gastric cancer (GC) that phosphorylates serine and threonine residues. Here, we showed that the kinase activity of DCLK1 orchestrated cancer cell–intrinsic and–extrinsic processes that led to pro-invasive and pro-metastatic reprogramming of GC cells. Inhibition of the kinase activity of DCLK1 reduced the growth of subcutaneous xenograft tumors formed from MKN1 human gastric carcinoma cells in mice and decreased the abundance of the stromal markers α-Sma, vimentin, and collagen. Similar effects were seen in mice with xenograft tumors formed from MKN1 cells expressing a kinase-inactive DCLK1 mutant (MKN1 D511N ). MKN1 D511N cells also had reduced in vitro migratory potential and stemness compared with control cells. Mice orthotopically grafted with MKN1 cells overexpressing DCLK1 (MKN1 DCLK1 ) showed increased invasiveness and had a greater incidence of lung metastases compared with those grafted with control MKN1 cells. Mechanistically, we showed that the chemokine CXCL12 acted downstream of DCLK1 in cultured MKN1 cells and in mice subcutaneously implanted with gastric tumors formed by MKN1 DCLK1 cells. Moreover, inhibition of the kinase activity of DCLK1 or the expression of DCLK1 D511N reversed the pro-tumorigenic and pro-metastatic phenotype. Together, this study establishes DCLK1 as a broadly acting and potentially targetable promoter of GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doublecortin-Like KinasesStomach NeoplasmsProtein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsDisease ProgressionPhenotypeAnimalsHumansMiceCell Line, TumorCell MovementCarcinogenesis

Substanzen

Doublecortin-Like KinasesProtein Serine-Threonine KinasesDCLK1 protein, humanIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.
  • School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.
  • ACRF Chemical Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
  • Department of Chemistry and Biochemistry and the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
  • Department of Chemical and Systems Biology, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.

ORCID-Profile: Shoukat Afshar-Sterle, Annalisa L E Carli, Ryan O'Keefe, Stefanie Fischer, David Baloyan, Lena Elias, Onisha Patel, Fleur M Ferguson, Moritz F Eissmann, Ashwini L Chand, Nathanael S Gray, Rita Busuttil, Alex Boussioutas, Isabelle S Lucet, Matthias Ernst, Michael Buchert

Förderung

  • National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellowship
  • Program Grant
  • Investigator Grant
  • NHMRC Project Grant
  • DF/HCC GI SPORE Developmental Research Project Award

Zitieren

APA

Afshar-Sterle, S., Carli, A. L. E., O'Keefe, R., Tse, J., Fischer, S., Azimpour, A. I., Baloyan, D., Elias, L., Thilakasiri, P., Patel, O., Ferguson, F. M., Eissmann, M. F., Chand, A. L., Gray, N. S., Busuttil, R., Boussioutas, A., Lucet, I. S., Ernst, M., & Buchert, M. (2024). DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression. Science Signaling, 17(854). https://doi.org/10.1126/scisignal.abq4888

Vancouver

Afshar-Sterle S, Carli ALE, O'Keefe R, Tse J, Fischer S, Azimpour AI, et al. DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression. Science Signaling. 2024;17(854). doi:10.1126/scisignal.abq4888

BibTeX
@article{AfsharSterle2024,
  author = {Afshar-Sterle, Shoukat and Carli, Annalisa L E and O'Keefe, Ryan and Tse, Janson and Fischer, Stefanie and Azimpour, Alexander I and Baloyan, David and Elias, Lena and Thilakasiri, Pathum and Patel, Onisha and Ferguson, Fleur M and Eissmann, Moritz F and Chand, Ashwini L and Gray, Nathanael S and Busuttil, Rita and Boussioutas, Alex and Lucet, Isabelle S and Ernst, Matthias and Buchert, Michael},
  title = {DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression},
  journal = {Science Signaling},
  year = {2024},
  volume = {17},
  number = {854},
  doi = {10.1126/scisignal.abq4888}
}
Kostenlos starten →